UBS O'Connor’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-149,913
| Closed | -$1.11M | – | 343 |
|
|
2024
Q4 | $1.11M | Buy |
149,913
+36,136
| +32% | +$267K | 0.03% | 214 |
|
|
2024
Q3 | $1.07M | Buy |
+113,777
| New | +$1.07M | 0.03% | 268 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 498 |
|
|
2024
Q1 | – | Sell |
-104,059
| Closed | -$846K | – | 480 |
|
|
2023
Q4 | $846K | Sell |
104,059
-137,915
| -57% | -$1.12M | 0.03% | 282 |
|
|
2023
Q3 | $1.1M | Sell |
241,974
-47,410
| -16% | -$216K | 0.02% | 316 |
|
|
2023
Q2 | $2.04M | Sell |
289,384
-18,828
| -6% | -$133K | 0.04% | 286 |
|
|
2023
Q1 | $1.88M | Buy |
+308,212
| New | +$1.88M | 0.04% | 329 |
|
|
2022
Q4 | – | Sell |
-202,872
| Closed | -$1.94M | – | 157 |
|
|
2022
Q3 | $1.94M | Sell |
202,872
-54,000
| -21% | -$517K | 0.02% | 625 |
|
|
2022
Q2 | $2.84M | Buy |
+256,872
| New | +$2.84M | 0.03% | 477 |
|